Clinical Trial Update: Botulinum for Chronic Exertional Compartment Syndrome [Phase 2, Phase 3]

View source ↗

Summary

The study investigating botulinum for chronic exertional compartment syndrome (Phase 2/Phase 3) was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exertional Compartment Syndrome

Drugs mentioned

• botulinum (botulinum toxin)

Snippet

Sponsor: 375th Medical Group, Scott Air Force Base | Conditions: Chronic Exertional Compartment Syndrome | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2024-03-05